The Securities & Exchange Commission (SEC) has accused Cassava's founder and former chief executive Remi Barbier and former ...

Rebecca Douglas is a strategic leader with a passion for nurturing talent. With an award-winning track record in developing ...

With 890 million people affected globally and 42% of American adults classified as obese, the allure of a "miracle" weight ...

It's a blow to the SCD community, as Oxbryta (voxelotor) was the first drug to reach the market that prevented sickle ...

Aqneursa has been approved to treat neurological symptoms associated with NPC in children and adults who weigh at least 15kg, ...

However, the UK’s innovative ‘Netflix style’ subscription model for antibiotics represents a groundbreaking approach to ...

After a long road that included a three-month delay as the agency pushed for additional data, the US FDA has approved Sanofi ...

AstraZeneca's EGFR inhibitor Tagrisso has been approved by the FDA for a new lung cancer indication that could make it a ...

J&J said its latest bankruptcy bid is backed by around 83% of the 60,000-plus claimants cited in lawsuits, who are claiming ...

The 19th century was a period of immense innovation for medicine in Scotland, marked by breakthroughs in anaesthetics, ...

It's another setback for the LAG-3 category in MSS colorectal cancer, coming after Bristol-Myers Squibb's combination of PD-1 ...

BMS swooped on Karuna towards the end of last year, shortly after AbbVie agreed an $8.7 billion deal to acquire Cerevel ...